Not offered yet, on purpose.
Peptide therapy is one of the fastest-moving corners of metabolic medicine, and one of the least carefully sold. The gap between what's promised online and what's supported by evidence and permitted by regulation is wide, and it changes month to month.
We'd rather be late and right than early and loose. Before Peri offers anything in this category, every candidate goes through two reviews: a clinical read of the evidence, and a legal and regulatory read of what can responsibly be provided. Whatever survives both is what you'll see here, with its limits stated as plainly as its uses.
We'll publish specifics once that review is complete, closer to our Late 2026 opening in Draper, Utah. Until then we won't name compounds or make promises we haven't earned. If this is an area you're watching, the waitlist is where the details land first.